BRIEF published on 08/06/2024 at 10:05, 2 years 2 months ago QUANTRO Therapeutics obtient une subvention de recherche autrichienne clé pour faire progresser le développement de la plateforme Découverte De Médicament QUANTRO Thérapeutique Bourse FFG Plateforme Transcriptomique Multiplexage
PRESS RELEASE published on 08/06/2024 at 10:00, 2 years 2 months ago QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform QUANTRO Therapeutics secures Austrian research grant to accelerate cutting-edge platform development, enabling multiplex target screening in drug discovery Drug Discovery QUANTRO Therapeutics Austrian Research Grant Transcriptomic Discovery Platform Multiplexing Capabilities
BRIEF published on 06/04/2024 at 23:12, 2 years 4 months ago QUANTRO Therapeutics Reaches Milestone in Collaboration with Boehringer Ingelheim Cancer Treatments R&D Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors
BRIEF published on 06/04/2024 at 23:12, 2 years 4 months ago QUANTRO Therapeutics franchit une étape importante en collaboration avec Boehringer Ingelheim Boehringer Ingelheim QUANTRO Thérapeutique Traitements Contre Le Cancer Facteurs De Transcription Collaboration R&D
PRESS RELEASE published on 06/04/2024 at 23:07, 2 years 4 months ago QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments QUANTRO Therapeutics achieves key milestone in collaboration with Boehringer Ingelheim for first-in-class cancer treatments using proprietary technology Cancer Treatments Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors R&D Program
PRESS RELEASE published on 04/04/2023 at 09:30, 3 years 6 months ago QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer
Published on 10/19/2026 at 09:05, 3 hours 20 minutes ago BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Published on 10/17/2026 at 03:20, 2 days 9 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 9 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 12 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 12 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/19/2026 at 12:14, 11 minutes ago More Than a Trophy: Africa’s Moment to Champion Women’s Football (By Isha Johansen)
Published on 10/19/2026 at 11:55, 30 minutes ago HNS 2026 | Huawei Launches Newly Upgraded Stellar Intelligent Fabric for the European Market
Published on 10/19/2026 at 11:30, 55 minutes ago HNS 2026 | Huawei and Industry Organizations Release High-Quality 10 Gbps Intelligent Campus Network Technical and Standard White Paper in Europe
Published on 10/19/2026 at 11:45, 39 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 12 au 16 octobre 2026
Published on 10/19/2026 at 11:45, 39 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from October 12 to October 16, 2026
Published on 10/19/2026 at 10:49, 1 hour 35 minutes ago 261019 BENETEAU Transactions sur actions propres
Published on 10/19/2026 at 08:15, 4 hours 10 minutes ago Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/19/2026 at 08:15, 4 hours 10 minutes ago Carrefour renforce son leadership dans le commerce de proximité en France avec l’acquisition de Codifrance
